Not a healthcare professional? Visit our Public site

report_adverse_events REPORT ADVERSE EVENT Login Register notification bell

Placeholder

    Contact us REQUEST A REPRESENTATIVE

    Your browser is not supported.

    To view this content, please use one of the following browsers:

    • Microsoft Edge
    • Chrome
    • Safari
    image
    Respiratory
    event image
    Respiratory
    therapy icon
    Respiratory

    Asthma Management in the post-COVID Era

    Asthma Management in the post-COVID Era
    Language Icon English
    duration icon 1:02:44
    Event topic Icon Asthma Management in a post-COVID Era
    Respiratory Respiratory
    Select Therapy Icon

    Prof Alberto Papi Professor Carlos Robalo Cordeiro

    This on demand Asthma Management in the post-COVID Era talk with experts sharing their best practices and views on treating asthma in relation to COVID and optimising the treatment for patients.

    Prof Alberto Papi

    Professor of respiratory medicine and

    Vice President of the School of Medicine at the University of Ferrara, Italy, and

    Director of the Respiratory Unit of the Department of Emergency Medicine at

    St. Anna University Hospital, Ferrara.

    Professor Papi is also an honorary clinical lecturer at the University of Southampton
    Watch Now
    Prescribing information for Flutiform fluticasone propionate/formoterol
    Subscribe to Respiratory

    Reporting adverse events

    Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.

    Adverse events should also be reported to Napp Pharmaceuticals Limited on 01223 424444 or drugsafetyUKandROI@mundipharma.com.